PHRI Lectureships

Max Halperin Emeritus Professor of Biostatistics, former Chair of the Department of Biostatistics and Medical Informatics at the University of Wisconsin – Madison. Former chief of the Biostatistics Branch at the National Heart, Lung and Blood Institute at the National Institutes of Health.

Research interests include the design, data monitoring and analysis of clinical trials, especially large Phase III randomized clinical trials. He is well known for his work on sequential statistical methods for monitoring interim data for early evidence of intervention benefit or possible harm.

Founder and President Emerita of WCG Statistics Collaborative, Janet Wittes is a Fellow of the American Statistical Association, the Society for Clinical Trials, and the American Association for the Advancement of Science, and an elected member of the International Statistical Institute.

Interim Analyses: Rules or Guidelines: A guide from and for the perplexed

Senior Scientist, Clinical Epidemiology Program, University of Ottawa
Associate Professor, School of Epidemiology and Public Health, University of Ottawa

The Promise and Pitfalls of Stepped Wedge Cluster Randomized Trials Watch the recorded lectureship.

Professor and Associate Chair, and Director of Collaborative Studies Coordinating Center, University of North Carolina

Opportunities and Challenges in Clinical Research with the Use of Big Data and Novel Trial Designs

Professor of Statistical Science & Research Professor of Global Health, Duke University

Challenges in Modeling Associations Among Environmental and Behavioural Exposures and Health Outcomes

Professor of Biostatistics – University of Washington

Use of Biomarkers as Replacement Endpoints in Clinical Trials

Vice Chair for Scientific Innovation, Department of Medicine, Brigham and Women’s Hospital | Harvard Medical School

Creating Learning Health Systems to Integrate Care, Translation and Discovery

• A Practical Approach to the Use of Genetics in the Clinical Management of Cardiovascular Disease
• Changing the Scale of Biomedical Research in a Digital Era

Arthur L. Bloomfield Professor of Medicine

Chairman of the Department of Medicine

Stanford University

Key ACS Lessons over the Last 25-30 Years Education and Research in an Era of Quality, Big Data, Precision Medicine, and Digital Health Rethinking Randomized Trials

Head of Nuffield Department of Population Health

BHF Professor of Medicine and Epidemiology

University of Oxford

Fellow of the Academy of Medical Sciences Fellow of the Royal Society

Randomization vs. Observation: Statin Therapy in the Real World Evolve or Die: The Urent Need to Streamline Randomized Trails

Distinguished Scholar in Cardiovascular Science, Baylor Heart and Vascular Institute

Baylor University Medical Center

Historical Paradigms for Understanding Heart Failure: An Exploration of How Many Times We Have Been Wrong Neprilysin Inhibitors

Head, Radcliffe Department of Medicine

Professor of Cardiovascular Medicine, University of Oxford

Honorary Consultant in Cardiology, John Radcliffe Hospital

Director, British Heart Foundation

Centre of Research Excellence at Oxford

Genomic Medicine - Hype or Hope? Genetic Insights that Impact on Diagnosis and Treatment in Hypertrophic Cardiomyopathy

Professor of Cardiology, Institute of Cardiovascular and Medical Sciences, University of Glasgow
Inaugural Eugene Braunwald Scholar in Cardiovascular (CV) Disease, Brigham and Women’s Hospital

Success in Heart Failure Understand the latest advances in pharmacological therapy for HF-REF Understand the latest advances in device therapy for HF-REF c) Understand the latest therapeutic efforts in HF-PEF

Distinguished Hersey Professor of Medicine, Harvard Medical School

Lessons from Recent TIMI Trials on Diabetes and Atrial Fibrillation Top 10 Achievements in Cardiology

Professor & Chairman, Cardiology & Cardiovascular Center University Hospital Zurich

From Eisenhower’s Heart Attack to Modern Management of Acute Coronary Syndrome Aging and Longevity Genes as Mediators of Cardiovascular Disease

Professor of Internal Medicine Specialized in Vascular Medicine Academic Medical Center Amsterdam

Management of Venous Thromboembolism – The Hamilton Legacy Treatment of Venous Thromboembolism Relation Venous and Arterial Thrombosis and the Role of Statins

Honorary Consultant, John Radcliffe Hospital, Oxford, UK

For AMI, thrombolysis is now dead - but has it been murdered? Serendipity in Medical Careers - can it still occur? Role of circulatory rhythms in health & disease: Music, mantras & prayer  

Professor, Department of Neurology, University of Texas Health Sciences Center

Atrial Fibrillation and Stroke: The First 100 Years What’s New in Stroke? The Top 10 Studies for 2006 -2008

Professor, Clinical Cardiology Cardiac and Vascular Sciences

St. George’s Hospital, London, UK

Acquired QT Prolongation and Cardiovascular Risk New Antiarrhythmic Drugs for Atrial Fibrillation

Professor of Medicine and Director, Disease Management, University of Montreal

Canada's Health: Perceptions, Politics and Possibilities Patient Adherence and Concordance in Chronic Care Disease Management as a Chronic Model: A Cardiologist's View

Emeritus Professor of Medicine, University of Oxford

Nuffield Department of Clinical Medicine

Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU), Oxford, UK

Proof of Causality Deduction from Epidemiological Observation Tobacco: A Medical History Quantification of the Benefits of Alcohol: An Epidemiological Problem Clinical Discussion of Major Projects with Investigators Identification of Tobacco as One of the Great Killers

Director, Public Health Policy Group & Chairman, International Obesity Task Force (IASO/OTF)
London, UK

Challenges and Controversies in the Management of Chronic Diseases: The Case of Obesity Managing the New Epidemic of Obesity The Sensitivity of Asians to the Co-Morbidities of Weight Gain The High Global Burden of Disease from Obesity

Emeritus Professor, Medical Statistics and Epidemiology, Nuffield Department of Population Health

University of Oxford, UK

Halving Premature Death Getting the BP Story Right Future Worldwide Health Effects of Current Smoking Patterns

Editor-in-Chief, The Lancet

The Journalism of Science: Justifiable Controversy or Jeopardized Credibility?

Scientific Director, McGill University Genome Québec Innovation Centre

Understanding the Genetic Basis of Human Health and Disease Can Genetics Improve Healthcare?

Editor-in-Chief, The Lancet

Planetary Health: A Global Science for the 21st Century

Professor Emeritus, University of Milano-Bicocca, Italy
President, European Society of Hypertension (ESH) Foundation / Chairman, ESH Educational Board

What are the Practical Implications of Recent Trials for the Practicing Clinician to Reduce Cardiovascular Disease in Hypertension?

Principal Director, The George Institute for Global Health

Professor, Cardiovascular Medicine & Epidemiology, University of Sydney

Professor of Medicine, James Martin Fellow, University of Oxford

Professor of Public Health, Peking University

High blood pressure - what to do about the world’s leading cause of illness Innovation, entrepreneurship and global health What do physicians and supermarket checkout assistants have in common? Imminent extinction by computer!

Professor & Chair of Clinical Epidemiology, Public Health & Policy, University of Liverpool

Preventing Cardiac Deaths in Canada: Past and Future NCD Prevention Politics: Pills or Policies? Science or Showbiz? Using the Media to Support your Public Health Interventions

Professor – University of Bristol

Director of the MRC Centre for Causal Analyses in Translational Epidemiology

The Limits of Personalised Medicine: Epidemiological Reflections Mendelian randomization in cardiovascular disease: what does the future hold?

London School of Hygiene and Tropical Medicine

Looking Upstream: New perspectives from around the world on the social and environmental influences of health

Chair of the Department of Anesthesiology and Pain Medicine; Professor of Anesthesia and Physiology – University of Toronto. Former Canada Research Chair in Anesthesia

Preserving Brain Function after Anesthesia and Surgery: To understand the incidence and risk factors associated with postoperative neurocognitive deficits; to learn about the new nomenclature for postoperative neurocognitive deficits and recent practice guidelines; and to identify mechanisms underlying postoperative neurocognitive deficits and potential new treatments.

Professor of Vascular Surgery, University of Oxford, UK

40 Years of Carotid Interventional Trials: Where we will be in 10 years' time?

Professor, Department of Anesthesia, Monash University, Melbourne, Australia

Large Multicentre Trials in Anesthesia

Cardiac Surgeon, Dalhousie University, Halifax Nova Scotia, Canada

Improving Cardiac Surgery Outcomes: Kaizen or Report Card Day

9th Annual Chanchlani Global Health Research Award and Lecture – part of a virtual 2021 International Women’s Day event

Canada’s first female First Nations surgeon, Dr. Nadine Caron is the founding First Nations Health Authority Chair (FNHA) in Cancer and Wellness at the University of British Columbia, where she also serves as co-director of the university’s Centre for Excellence in Indigenous Health (CEIH). Her main focus is Aboriginal Health and Canadian health policy and her work advocates for the needs and voices of northern, rural and Indigenous populations in Canada.

Topic: Perspectives of a First Nations Physician in Canada: Do you ever wonder what we think?

12 -4 pm EST, Monday, March 8th, 2021

Additional event speakers include:

• Dr. Zena Samaan – Associate Professor, Department of Psychiatry and Behavioural Neurosciences, McMaster University
• Dr. Harriet MacMillan – Chedoke Health Chair in Child Psychiatry, McMaster University
• Dr. Claudia Emerson – Director and Associate Professor, Institute on Ethics & Policy for Innovation, McMaster University

More about the half-day online event.

Professor and Director, Global Health Institute, University of Wisconsin-Madison
Lead author, United Nations Intergovernmental Panel on Climate Change (IPCC)

Can actions to solve today’s climate crisis create the largest health opportunity of our times?

• Multiple exposure routes through which climate change threatens our health
• Why actions to mitigate greenhouse gas emissions are so urgent, across all sectors
• How climate change mitigation policies in the energy, food, and transportation sectors can reduce the global burden of chronic diseases

Associate Editor, The Lancet

Cardiovascular Research in The Lancet: Past, Present and Future What Makes a High-Quality Paper?

Senior Fellow, Satcher Health Leadership Institute and Cardiovascular Research Institute

Adjunct Associate Professor, Community Health and Preventative Medicine, Morehouse School of Medicine

Chanchlani Global Health Research Award Recipient for 2019

Naming, Measuring and Addressing the Impacts of Racism on Health View Video